CW June 2000Issue Number 6 June 2000 ISSN 10593802 Herceptin/Taxol Weekly in Metastatic Breast CancerIncreasing the frequency of administration of Taxol (paclitaxel) in patients who are also receiving Herceptin (trastuzumab) for metastatic breast cancer may provide advantages over current treatment regimens using the two drugs.
Go to Previous Page Source & Additional Reading Reports from ASCO Meeting. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW June 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |